U.S. Online Retail and Ecommerce Stock News

Primoris Services (PRIM) is back in focus after first quarter 2026 results showed lower sales and profit, tied largely to renewables project issues, and a shareholder rights investigation raised fresh questions around prior disclosures. See our latest analysis for Primoris Services. The Q1 2026 miss and lowered outlook have led to a sharp reset in expectations, with the stock down 43.5% over a 7 day share price return and weaker returns across recent months. However, the 1 year and multi year...

First Busey (BUSE) is back on investors’ radar after first quarter 2026 results showed a shift from a loss to a profit, supported by higher net interest income and sharply lower net charge-offs. See our latest analysis for First Busey. The share price is now US$26.61, with a year to date share price return of 11.34% and a 1 year total shareholder return of 23.62%. This points to steady momentum that aligns with the profit rebound, reduced net charge offs and completion of the long running...

ATI Inc. recently reported past first-quarter 2026 results showing modest sales growth to US$1,151.5 million and higher net income of US$118.2 million, while also completing a US$655.12 million share repurchase program covering 8,819,175 shares since its September 2024 authorization. Together, stronger earnings per share alongside a completed multi-year buyback highlight ATI’s focus on boosting profitability and returning capital to shareholders. With Q1 margin improvement now clear, we’ll...

Republic Services, Inc. recently reported first-quarter 2026 results, with revenue of US$4.11 billion, net income of US$525 million and diluted EPS of US$1.70, while also affirming a quarterly dividend of US$0.625 per share payable on July 15, 2026. The company coupled this earnings performance with margin expansion driven by disciplined pricing and cost control, alongside ongoing investments in AI, digital tools, acquisitions, and fleet electrification aimed at improving efficiency and...

Bank of New York Mellon Corporation (BK) has agreed to work with Finstreet Limited and ADI Foundation to offer Bitcoin and Ethereum custody services in the UAE, tying into the region’s push toward regulated digital finance. See our latest analysis for Bank of New York Mellon. At a share price of US$130.50, BNY has moved sideways in the very short term, with a small pullback over the past week. Its 11.5% year to date share price return and strong multi year total shareholder returns indicate...

Snowflake (SNOW) is back in focus after o9 Solutions rolled out a Connected Application that plugs its Digital Brain planning platform directly into Snowflake’s AI Data Cloud, tightening the link between enterprise data and day to day decisions. See our latest analysis for Snowflake. Snowflake’s recent AI and o9 integrations have arrived alongside a 30 day share price return of 25.88%, though the stock is still down 29.65% year to date and the 1 year total shareholder return is down 15.56%,...

nLIGHT, Inc. has reported its first-quarter 2026 results, with revenue rising to US$80.18 million and net income turning positive at US$0.65 million, while also launching its HADES high‑energy laser portfolio and expanding directed energy operations in Torino, Italy. Together, the earnings improvement, new directed energy products, and European expansion underscore nLIGHT’s increasing focus on defense‑oriented laser systems and globally distributed manufacturing. We’ll now examine how this...

In early May 2026, Onto Innovation Inc. reported first-quarter 2026 results showing sales of US$291.95 million, higher than a year earlier, but with net income dropping to US$33.75 million and diluted earnings per share from continuing operations easing to US$0.67. At the same time, the company issued second-quarter 2026 guidance calling for US$320 million to US$330 million in revenue and GAAP diluted earnings per share of US$1.09 to US$1.18, highlighting management’s confidence despite the...

First quarter earnings put Leggett & Platt’s recent performance in focus Leggett & Platt (LEG) reported first quarter 2026 earnings with sales of US$918.2 million and net income of US$20 million, compared with US$1,022.1 million and US$30.6 million a year earlier. These results give you fresh numbers to assess how the bedding, furniture, and engineered components manufacturer is currently performing and how the stock might reflect changes in profitability and scale. See our latest analysis...

AtaiBeckley (ATAI) drew fresh attention after reporting Phase 2a data for EMP-01 in Social Anxiety Disorder, showing symptom and avoidance reductions with no serious adverse events and positioning the program for further outpatient-focused development. See our latest analysis for AtaiBeckley. Against this backdrop, AtaiBeckley’s 1 month share price return of 10.71% and 90 day share price return of 4.68% suggest momentum has picked up recently. The 1 year total shareholder return of 179.86%...

Analyst optimism and recent stock performance Recent analyst optimism around TAL Education Group (NYSE:TAL), including higher earnings estimates and a favorable Zacks Rank #1 rating, has drawn fresh attention to the stock following its recent share price gains. See our latest analysis for TAL Education Group. At a latest share price of US$11.09, TAL’s short term share price has been choppy, with a 1 day move down 2.72% and a 90 day share price return down 9.62%. The 3 year total...

Rhythm Pharmaceuticals (RYTM) stock has been in focus after a cluster of catalysts, including U.S. and European approvals for IMCIVREE in acquired hypothalamic obesity, as well as first quarter revenue of US$60.11 million alongside a net loss of US$55.64 million. See our latest analysis for Rhythm Pharmaceuticals. The recent approvals and data updates appear to be feeding into Rhythm Pharmaceuticals’ share price performance, with the stock at US$94.17 and a 7 day share price return of 10.04%...

In early May 2026, Proto Labs reported first-quarter revenue of US$139.34 million and diluted earnings per share of US$0.33, issued new quarterly and full-year 2026 guidance, and confirmed leadership changes including the upcoming appointment of Bernardo Parlange as Chief Commercial Officer and the planned retirement of long-time COO Mike Kenison. Together, the stronger quarterly performance, upbeat guidance, and creation of a new global commercial leadership role highlight Proto Labs’ focus...

EverCommerce (EVCM) drew fresh investor attention after reporting first quarter 2026 results with revenue of US$147.47 million and net income of US$7.17 million, compared with a net loss a year earlier. See our latest analysis for EverCommerce. The latest results and progress on AI enabled products have coincided with building momentum in the stock, with a 30 day share price return of 9.62% and a 1 year total shareholder return of 5.28%. If EverCommerce's AI push has caught your eye, it can...

Ardelyx (ARDX) is back in focus after presenting new long term data on XPHOZAH at the National Kidney Foundation’s Spring Clinical Meetings, reinforcing the drug’s safety profile in dialysis patients with hyperphosphatemia. See our latest analysis for Ardelyx. The latest XPHOZAH data comes after a busy few weeks that included first quarter results and reiterated 2026 revenue guidance. Yet the stock has eased in the very short term with a 1-day share price return of 2.87% and a 7-day share...

Skyward Specialty Insurance Group (SKWD) has drawn fresh attention after first quarter 2026 earnings showed revenue of US$475.87 million and net income of US$49.73 million. The results reflect contributions from the Apollo acquisition. See our latest analysis for Skyward Specialty Insurance Group. At a share price of US$46.69, the stock has seen a 6.99% 7 day share price return and a 2.59% 1 day share price return around the earnings release, while the 1 year total shareholder return has...

We'd be surprised if Regions Financial Corporation ( NYSE:RF ) shareholders haven't noticed that an insider, Brian...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Shareholders in Insmed Incorporated ( NASDAQ:INSM ) had a terrible week, as shares crashed 28% to US$101 in the week...

Readers hoping to buy Flowco Holdings Inc. ( NYSE:FLOC ) for its dividend will need to make their move shortly, as the...

Alphabet (NasdaqGS:GOOGL) plans its first yen denominated bond issue, announced within the last day, as part of a wider multi currency debt program aimed at funding AI infrastructure. The company is expanding beyond recent euro and Canadian dollar bond offerings to raise capital in Japan's bond market. Alphabet is also exploring new AI related hardware and infrastructure investments in India, including server manufacturing and drone technology. Together, these moves point to a larger shift...

In the first quarter of 2026, International Bancshares Corporation reported net interest income of US$165.63 million and net income of US$102.19 million, with basic and diluted earnings per share from continuing operations of US$1.64, all modestly higher than a year earlier. The year-over-year earnings growth was supported by higher interest income on investment and loan portfolios, reduced interest expense on deposits, and ongoing efficiency efforts including AI-driven initiatives. With...

New Horizon Aircraft Ltd. has now completed a registered direct follow-on equity offering, raising approximately US$19.90 million through the sale of 9,254,889 Class A ordinary shares at US$2.15 each, at a small per-share discount, to support its hybrid-electric VTOL development and general corporate needs. This funding round, involving institutional investors and placement agent warrants, is intended to accelerate the Cavorite X7 hybrid-electric VTOL program while temporarily limiting...

Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$78.69 million, while accelerating investment in late-stage development of its lead antibody barzolvolimab. At the same time, Celldex completed Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria six months ahead of plan and raised about US$345 million in a follow-on offering, extending its funding runway for ongoing...